Zoetis Inc - Class A

$79.57
Market Cap 33.59B
ROE 62.1%
Gross Margin 71.7%
Debt/Equity 2.9
Current Ratio 3.2
Revenue QoQ 2.9%
EPS QoQ 0.1%
F-Score 5

About

The action alleges Zoetis and certain officers made materially false and misleading statements regarding the Company's Companion Animal product portfolio, concealing safety concerns with Librela, competitive losses in parasiticides and dermatology, and declining veterinarian confidence. Four corrective disclosures between August 2025 and May 2026 allegedly removed artificial inflation from ZTS shares. "The lead plaintiff process is designed to ensure the class is represented by shareholders with substantial interests in the outcome of the litigation. Investors with losses in Zoetis during the Class Period should evaluate whether seeking appointment serves their interests before the July 27 deadline." -- Joseph E. Levi, Esq. Levi & Korsinsky, LLP | Top 50 Securities Firm | (212) 363-7500 | www.zlk.com Frequently Asked Questions About the ZTS Lawsuit Q: What is the ZTS lead plaintiff deadline? A: The deadline to apply for lead plaintiff appointment is July 27, 2026. This deadline applies only to investors seeking to serve as lead plaintiff. Class members who do not apply may still participate in any recovery without taking action before this date. Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run. Q: What if I missed the lead plaintiff deadline? A: The deadline applies only to investors seeking lead plaintiff appointment. Class members who miss it can still participate in any settlement or recovery. Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs. Q: What documents do I need to make a claim? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices. Q: How long will the lawsuit take to resolve? A: Securities class actions typically take two to four years from initial filing to resolution. CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. Ed Korsinsky, Esq. 33 Whitehall Street, 27th Floor New York, NY 10004 [email protected] Tel: (212) 363-7500 Fax: (212) 363-7171 SOURCE Levi & Korsinsky, LLP

Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
12.71
vs median 32.40
P/B
10.39
vs median 2.75
ROE
0.62
vs median 0.12

Decent quality with acceptable fundamentals

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics